Biodesix, Inc. (BDSX)
NASDAQ: BDSX · Real-Time Price · USD
26.63
+2.60 (10.82%)
At close: Aug 21, 2026, 4:00 PM EDT
27.10
+0.47 (1.76%)
After-hours: Aug 21, 2026, 7:38 PM EDT
Biodesix Market Cap
Biodesix has a market cap or net worth of $280.98 million as of August 21, 2026. Its market cap has increased by 367.25% in one year.
Market Cap
280.98M
Enterprise Value
322.78M
1-Year Change
367.25%
Ranking
Category
Stock Price
$26.63
ChartMarket Cap Chart
Since October 28, 2020, Biodesix's market cap has decreased from $336.31M to $280.98M, a decrease of -16.45%. That is a compound annual growth rate of -3.04%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 280.98M | 419.38% |
| Dec 31, 2025 | 54.10M | -75.69% |
| Dec 31, 2024 | 222.56M | 33.69% |
| Dec 29, 2023 | 166.48M | -5.38% |
| Dec 30, 2022 | 175.94M | 23.06% |
| Dec 31, 2021 | 142.97M | -73.28% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Oct 28, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Freenome | 1.54B |
| OPKO Health | 1.09B |
| Castle Biosciences | 987.36M |
| Fulgent Genetics | 543.15M |
| Myriad Genetics | 305.12M |
| Exagen | 179.99M |
| Insight Molecular Diagnostics | 143.33M |
| Quantum Cyber | 121.06M |